0.16CNY
395.26 MCNY
15.34 BCNY
1.20 B
About HARBIN PHARMACEUTICAL GROUP CO.,LTD.
Sector
Headquarters
Harbin
Employees (FY)
9.85 K
Website
Founded
1991
ISIN
CNE0000009T3
FIGI
BBG000BG02Z8
Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, wholesale and retail of pharmaceutical products. Its products include calcium gluconate & zinc gluconate oral solution, amoxicillin capsules, shuanghuanglian oral liquid, alprostadil injection, pediatric acetaminophen yellow, namin granules, lacidipine tablets, cefotiam hydrochloride for injection, ibuprofen granules, xingai zhonggai calcium tablets. The company provides antibiotics, OTC, healthcare products, modern chinese medicines, biopharmaceuticals, animal vaccines and medicine circulations. Harbin Pharmaceutical Group was founded on December 28, 1991 and is headquartered in Harbin, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600664 is 2.81 CNY — it has increased by 1.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HARBIN PHARMACEUTICAL GROUP CO.,LTD. stocks are traded under the ticker 600664.
HARBIN PHARMACEUTICAL GROUP CO.,LTD. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
600664 stock is 2.17% volatile and has beta coefficient of 1.21. Check out the list of the most volatile stocks — is HARBIN PHARMACEUTICAL GROUP CO.,LTD. there?
Yes, you can track HARBIN PHARMACEUTICAL GROUP CO.,LTD. financials in yearly and quarterly reports right on TradingView.
600664 stock has fallen by 0.71% compared to the previous week, the month change is a 7.57% fall, over the last year HARBIN PHARMACEUTICAL GROUP CO.,LTD. has showed a 10.22% decrease.
600664 net income for the last quarter is 104.76 M CNY, while the quarter before that showed 107.79 M CNY of net income which accounts for −2.81% change. Track more HARBIN PHARMACEUTICAL GROUP CO.,LTD. financial stats to get the full picture.
HARBIN PHARMACEUTICAL GROUP CO.,LTD. dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600664 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HARBIN PHARMACEUTICAL GROUP CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 9.85 K employees. See our rating of the largest employees — is HARBIN PHARMACEUTICAL GROUP CO.,LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HARBIN PHARMACEUTICAL GROUP CO.,LTD. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HARBIN PHARMACEUTICAL GROUP CO.,LTD. stock shows the sell signal. See more of HARBIN PHARMACEUTICAL GROUP CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HARBIN PHARMACEUTICAL GROUP CO.,LTD. EBITDA is 902.25 M CNY, and current EBITDA margin is 5.99%. See more stats in HARBIN PHARMACEUTICAL GROUP CO.,LTD. financial statements.